tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Future for Xilio Therapeutics: Strong Financial Position and Encouraging Trial Results Support Buy Rating
PremiumRatingsPromising Future for Xilio Therapeutics: Strong Financial Position and Encouraging Trial Results Support Buy Rating
1M ago
Xilio Therapeutics reports Q2 EPS (16c) vs (24c) last year
Premium
The Fly
Xilio Therapeutics reports Q2 EPS (16c) vs (24c) last year
2M ago
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
Premium
The Fly
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
2M ago
Xilio Therapeutics announces pricing of $50M public offering
PremiumThe FlyXilio Therapeutics announces pricing of $50M public offering
4M ago
Xilio Therapeutics Presents Phase 2 Trial Data Update
Premium
Company Announcements
Xilio Therapeutics Presents Phase 2 Trial Data Update
4M ago
Xilio Therapeutics announces offering of warrants, no amount given
Premium
The Fly
Xilio Therapeutics announces offering of warrants, no amount given
4M ago
Xilio Therapeutics reports Q1 EPS (18c) vs. (62c) last year
PremiumThe FlyXilio Therapeutics reports Q1 EPS (18c) vs. (62c) last year
5M ago
Xilio Therapeutics sees cash runway into 1Q26
Premium
The Fly
Xilio Therapeutics sees cash runway into 1Q26
5M ago
AbbVie Stock (ABBV) Up 8% on the Week as Company Soars Past Q1 Expectations
Premium
Market News
AbbVie Stock (ABBV) Up 8% on the Week as Company Soars Past Q1 Expectations
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100